Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Diabetes

  Free Subscription


02.12.2024

1 Am J Cardiol
1 Am J Clin Nutr
1 Biochem Biophys Res Commun
4 Diabet Med
13 Diabetes Care
17 Diabetes Obes Metab
6 Diabetologia
2 J Am Coll Cardiol
2 J Diabetes Complications
1 JAMA
1 Kidney Int
1 Metabolism
1 Nature
1 Obstet Gynecol
1 Ophthalmol Retina
5 PLoS One
1 Transplant Proc


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Cardiol

  1. WATANABE Y, Yoshikawa T, Arao K, Isogai T, et al
    Prevalence and Prognostic Impact of Diabetes in Takotsubo Syndrome: Insights from the Tokyo Cardiovascular Care Unit Network Registry.
    Am J Cardiol. 2024 Nov 22:S0002-9149(24)00819.
    PubMed         Abstract available


    Am J Clin Nutr

  2. RICKMAN RR, Widen EM, Lane CE, Abrego MR, et al
    Infant body composition trajectories differ by in utero exposure to gestational diabetes mellitus: a prospective cohort from birth to 12 months.
    Am J Clin Nutr. 2024 Nov 14:S0002-9165(24)00861.
    PubMed         Abstract available


    Biochem Biophys Res Commun

  3. TARIQ M, Sjogren M, Salehi A
    Sulindac prevents increased mitochondrial VDAC1 expression and cell surface mistargeting induced by pathological conditions in retinal cells.
    Biochem Biophys Res Commun. 2024;739:150558.
    PubMed         Abstract available


    Diabet Med

  4. DLUGATCH R, Rankin D, Evans M, Oliver N, et al
    Understanding inequities in access to diabetes technologies in children and young people with type 1 diabetes: Qualitative study of healthcare professionals' perspectives and views.
    Diabet Med. 2024 Nov 29:e15486. doi: 10.1111/dme.15486.
    PubMed         Abstract available

  5. DUNNE P, O'Mahony L, Culliney L, Byrne M, et al
    Exploring the lived experience of women with gestational diabetes: A cross-sectional Irish national survey.
    Diabet Med. 2024 Nov 28:e15489. doi: 10.1111/dme.15489.
    PubMed         Abstract available

  6. LAI ST, Styles SE, Boucsein A, Zhou Y, et al
    Parental perspectives following the implementation of advanced hybrid closed-loop therapy in children and adolescents with type 1 diabetes and elevated glycaemia.
    Diabet Med. 2024 Nov 25:e15448. doi: 10.1111/dme.15448.
    PubMed         Abstract available

  7. GOLDNEY J, Alabraba V, Sarkar P, Morgan H, et al
    Designing a regional clinical service for people with early-onset type 2 diabetes in England.
    Diabet Med. 2024 Nov 25:e15479. doi: 10.1111/dme.15479.
    PubMed         Abstract available


    Diabetes Care

  8. ZHENG W, Yuan X, Zhao J, Han W, et al
    Neonatal Amino Acids and Acylcarnitines Associated With Maternal Blood Glucose Levels Throughout Pregnancy: Insights From the Beijing Birth Cohort Study.
    Diabetes Care. 2024;47:2128-2138.
    PubMed         Abstract available

  9. SWEETING A, Enticott J, Immanuel J, Hague WM, et al
    Relationship Between Early-Pregnancy Glycemia and Adverse Outcomes: Findings From the TOBOGM Study.
    Diabetes Care. 2024;47:2085-2092.
    PubMed         Abstract available

  10. WAGNER KA, Gleason JL, Chen Z, Zhang C, et al
    Maternal Glycemic Status and Longitudinal Fetal Body Composition and Organ Volumes Based on Three-Dimensional Ultrasonography.
    Diabetes Care. 2024;47:2180-2188.
    PubMed         Abstract available

  11. SHAW JLV, Bannuru RR, Beach L, ElSayed NA, et al
    Consensus Considerations and Good Practice Points for Use of Continuous Glucose Monitoring Systems in Hospital Settings.
    Diabetes Care. 2024;47:2062-2075.
    PubMed         Abstract available

  12. BONHOF GJ, Strom A, Jung T, Bodis KB, et al
    Cutaneous Carbonyl Stress Is Associated With Nerve Dysfunction in Recent-Onset Type 2 Diabetes.
    Diabetes Care. 2024 Nov 25:dc241799. doi: 10.2337/dc24-1799.
    PubMed         Abstract available

  13. HENNEKES MHCL, Haugvik S, de Wit M, Toschi E, et al
    Diabetes Body Project: Acute Effects of an Eating Disorder Prevention Program for Young Women With Type 1 Diabetes: A Multinational Randomized Controlled Trial.
    Diabetes Care. 2024 Nov 27:dc241599. doi: 10.2337/dc24-1599.
    PubMed         Abstract available

  14. GAO FM, Ali AS, Bellomo R, Gaca M, et al
    A Systematic Review and Meta-analysis on the Safety and Efficacy of Sodium-Glucose Cotransporter 2 Inhibitor Use in Hospitalized Patients.
    Diabetes Care. 2024;47:2275-2290.
    PubMed         Abstract available

  15. COGEN F, Rodriguez H, March CA, Munoz CE, et al
    Diabetes Care in the School Setting: A Statement of the American Diabetes Association.
    Diabetes Care. 2024;47:2050-2061.
    PubMed         Abstract available

  16. POWE CE
    One Step Closer to a Definition of Early Gestational Diabetes Mellitus: Secondary Analyses From the Treatment of Booking Gestational Diabetes Mellitus (TOBOGM) Randomized Trial.
    Diabetes Care. 2024;47:2076-2078.
    PubMed        

  17. COOPER ZW, O'Shields J, Ali MK, Chwastiak L, et al
    Effects of Integrated Care Approaches to Address Co-occurring Depression and Diabetes: A Systematic Review and Meta-analysis.
    Diabetes Care. 2024;47:2291-2304.
    PubMed         Abstract available

  18. PAGE B
    About the Editor: Kristina Utzschneider, MD: Improving Personalized Care by Classifying Subtypes Within Type 2 Diabetes.
    Diabetes Care. 2024;47:2036-2037.
    PubMed        

  19. SAEED ZI, Ostrominski JW, Aroda VR
    Polypharmacy in Type 2 Diabetes: Appropriate or Cause for Concern?
    Diabetes Care. 2024;47:2104-2106.
    PubMed        

  20. BACHA F
    Are Prediction Models Moving Closer to Clinical Application in the Diagnosis of Type of Diabetes in Youth?
    Diabetes Care. 2024;47:2102-2103.
    PubMed        


    Diabetes Obes Metab

  21. VALE C, Lourenco IM, Jordan G, Golovaty I, et al
    Early combination therapy with SGLT2i and GLP-1 RA or dual GIP/GLP-1 RA in type 2 diabetes.
    Diabetes Obes Metab. 2024 Nov 27. doi: 10.1111/dom.16077.
    PubMed         Abstract available

  22. ARMSTRONG MJ, Okanoue T, Sundby Palle M, Sejling AS, et al
    Similar weight loss with semaglutide regardless of diabetes and cardiometabolic risk parameters in individuals with metabolic dysfunction-associated steatotic liver disease: Post hoc analysis of three randomised controlled trials.
    Diabetes Obes Metab. 2024 Nov 28. doi: 10.1111/dom.16065.
    PubMed         Abstract available

  23. ADDALA A, Ritter V, Schneider-Utaka AK, Alamarie SA, et al
    Psychosocial outcomes in a diverse sample of youth and their families who initiated continuous glucose monitoring within the first year of type 1 diabetes diagnosis.
    Diabetes Obes Metab. 2024 Nov 27. doi: 10.1111/dom.16093.
    PubMed         Abstract available

  24. ENG PC, Lee SH, Der Teo AE, Lim DST, et al
    Postnatal glycaemic outcomes in women with high-risk gestational diabetes: Identifying key predictors for early intervention.
    Diabetes Obes Metab. 2024 Nov 27. doi: 10.1111/dom.16085.
    PubMed         Abstract available

  25. WANG W, Han Y, Jiang X, Shao J, et al
    Development of a predictive model for gastrointestinal side effects of metformin treatment in Chinese individuals with type 2 diabetes based on four randomised clinical trials.
    Diabetes Obes Metab. 2024 Nov 28. doi: 10.1111/dom.16095.
    PubMed         Abstract available

  26. WU A, Pu J, Emery A, Harris SB, et al
    Role of the liver in the sustained normalisation of A1c over 2 years following short-term insulin therapy in early type 2 diabetes.
    Diabetes Obes Metab. 2024 Nov 28. doi: 10.1111/dom.16099.
    PubMed         Abstract available

  27. SHAH R, Finlay AY, Ali FM, Otwombe K, et al
    Comparison of the impact of type 1 and type 2 diabetes on quality of life of families of patients: A UK cross-sectional study.
    Diabetes Obes Metab. 2024 Nov 24. doi: 10.1111/dom.16058.
    PubMed         Abstract available

  28. KRISTENSEN DK, Mose FH, Buus NH, Duus CL, et al
    SGLT2 inhibition improves endothelium-independent vasodilatory function in type 2 diabetes: A double-blind, randomized, placebo-controlled crossover trial.
    Diabetes Obes Metab. 2024 Nov 29. doi: 10.1111/dom.16097.
    PubMed         Abstract available

  29. LUNDEMOSE SB, McCarthy OM, Christensen MB, Laugesen C, et al
    Is low-dose glucagon needed and effective in preventing fasted exercise-induced hypoglycaemia in type 1 diabetes treated with the MiniMed 780G, an automated insulin delivery system?
    Diabetes Obes Metab. 2024 Nov 27. doi: 10.1111/dom.16103.
    PubMed         Abstract available

  30. WHELEHAN G, Dirks ML, West S, Abdelrahman DR, et al
    High-protein vegan and omnivorous diets improve peripheral insulin sensitivity to a similar extent in people with type 2 diabetes.
    Diabetes Obes Metab. 2024 Nov 27. doi: 10.1111/dom.16100.
    PubMed         Abstract available

  31. UMPIERREZ G, Gill J, Hood D, Li X, et al
    Treatment persistence, adherence and healthcare resource utilisation for iGlarLixi versus basal-bolus insulin or premixed insulin in older adult ethnic minorities with type 2 diabetes: SoliEthnicity study.
    Diabetes Obes Metab. 2024 Nov 27. doi: 10.1111/dom.16075.
    PubMed         Abstract available

  32. KASTRATI L, Alvarez-Martinez M, Thomas A, Thevis M, et al
    Effect of exercise on plasma insulin levels in individuals with type 1 diabetes: A systematic review and meta-analysis.
    Diabetes Obes Metab. 2024 Nov 26. doi: 10.1111/dom.16088.
    PubMed         Abstract available

  33. JIANG Y, Zhu H, Gong F
    Why does GLP-1 agonist combined with GIP and/or GCG agonist have greater weight loss effect than GLP-1 agonist alone in obese adults without type 2 diabetes?
    Diabetes Obes Metab. 2024 Nov 26. doi: 10.1111/dom.16106.
    PubMed         Abstract available

  34. GENG J, Ruan X, Wu X, Chen X, et al
    Network Mendelian randomisation analysis deciphers protein pathways linking type 2 diabetes and gastrointestinal disease.
    Diabetes Obes Metab. 2024 Nov 26. doi: 10.1111/dom.16087.
    PubMed         Abstract available

  35. SINGH J, Adel FW, Scott CG, Chen HH, et al
    Natriuretic peptide levels and predicting risk of developing new diabetes mellitus and metabolic syndrome.
    Diabetes Obes Metab. 2024 Nov 25. doi: 10.1111/dom.16073.
    PubMed         Abstract available

  36. DICEMBRINI I, Cavallo G, Ranaldi F, Scoccimarro D, et al
    Glycaemic response to pasta from three different wheat varieties in individuals with type 2 diabetes.
    Diabetes Obes Metab. 2024 Nov 25. doi: 10.1111/dom.16082.
    PubMed        

  37. LIU W, Hu X, Fang Y, Hong S, et al
    Development and external validation of an algorithm for self-identification of risk for microvascular complications in patients with type 1 diabetes.
    Diabetes Obes Metab. 2024 Nov 25. doi: 10.1111/dom.16068.
    PubMed         Abstract available


    Diabetologia

  38. WAT LW, Svensson KJ
    Novel secreted regulators of glucose and lipid metabolism in the development of metabolic diseases.
    Diabetologia. 2024;67:2626-2636.
    PubMed         Abstract available

  39. ZEMSKI BERRY KA, Garfield A, Jambal P, Zarini S, et al
    Oxidised phosphatidylcholine induces sarcolemmal ceramide accumulation and insulin resistance in skeletal muscle.
    Diabetologia. 2024;67:2819-2832.
    PubMed         Abstract available

  40. O CK, Fan B, Tsoi STF, Tam CHT, et al
    A polygenic risk score derived from common variants of monogenic diabetes genes is associated with young-onset type 2 diabetes and cardiovascular-kidney complications.
    Diabetologia. 2024 Nov 23. doi: 10.1007/s00125-024-06320.
    PubMed         Abstract available

  41. HANICK CJ, Peterson CM, Davis BC, Sabate J, et al
    Correction: A whole-food, plant-based intensive lifestyle intervention improves glycaemic control and reduces medications in individuals with type 2 diabetes: a randomised controlled trial.
    Diabetologia. 2024 Nov 25. doi: 10.1007/s00125-024-06332.
    PubMed        

  42. GALDERISI A, Carr ALJ, Martino M, Taylor P, et al
    Correction: Quantifying beta cell function in the preclinical stages of type 1 diabetes.
    Diabetologia. 2024 Nov 27. doi: 10.1007/s00125-024-06335.
    PubMed        

  43. TRICO D, Sacchetta L, Rebelos E, Cimbalo N, et al
    Postprandial hypoglycaemia after gastric bypass in type 2 diabetes: pathophysiological mechanisms and clinical implications.
    Diabetologia. 2024 Nov 29. doi: 10.1007/s00125-024-06312.
    PubMed         Abstract available


    J Am Coll Cardiol

  44. GYLDENKERNE C, Kahlert J, Thrane PG, Olesen KKW, et al
    2-Fold More Cardiovascular Disease Events Decades Before Type 2 Diabetes Diagnosis: A Nationwide Registry Study.
    J Am Coll Cardiol. 2024;84:2251-2259.
    PubMed         Abstract available

  45. SPERLING LS
    The "Ticking Clock" of Impending Diabetes: Cause for Concern or Window of Opportunity?
    J Am Coll Cardiol. 2024;84:2260-2263.
    PubMed        


    J Diabetes Complications

  46. GONZALEZ-VIDAL T, Rivas-Otero D, Ares-Blanco J, Lambert C, et al
    Real-life evaluation of consensus recommendations for transition to subcutaneous insulin in hyperosmolar hyperglycemic crises.
    J Diabetes Complications. 2024;38:108902.
    PubMed         Abstract available

  47. YARIBEYGI H, Maleki M, Forouzanmehr B, Kesharwani P, et al
    Exploring the antioxidant properties of semaglutide: A comprehensive review.
    J Diabetes Complications. 2024;38:108906.
    PubMed         Abstract available


    JAMA


  48. The Statistics of Diabetes.
    JAMA. 2024 Nov 27. doi: 10.1001/jama.2023.18494.
    PubMed        


    Kidney Int

  49. KRISHNAN S, Manoharan J, Wang H, Gupta D, et al
    Corrigendum to "CD248 induces a maladaptive unfolded protein response in diabetic kidney disease." Kidney International 2023;103:304-319.
    Kidney Int. 2024;106:1193-1196.
    PubMed        


    Metabolism

  50. WU Q, Zeng Y, Geng K, Guo M, et al
    The role of IL-1 family cytokines in diabetic cardiomyopathy.
    Metabolism. 2024 Nov 25:156083. doi: 10.1016/j.metabol.2024.156083.
    PubMed         Abstract available


    Nature

  51. SASS F, Ma T, Ekberg JH, Kirigiti M, et al
    NK2R control of energy expenditure and feeding to treat metabolic diseases.
    Nature. 2024;635:987-1000.
    PubMed         Abstract available


    Obstet Gynecol

  52. CHAKRABORTY P, Reynolds CA, McKetta S, Soled KRS, et al
    Sexual Orientation-Related Disparities in Neonatal Outcomes.
    Obstet Gynecol. 2024 Oct 3. doi: 10.1097/AOG.0000000000005747.
    PubMed         Abstract available


    Ophthalmol Retina

  53. GOLDBERG RA, Mar FA, Csaky K, Amador M, et al
    Resolution of Angiographic Macular Leakage with Faricimab Versus Aflibercept in Patients with Diabetic Macular Edema in YOSEMITE/RHINE.
    Ophthalmol Retina. 2024 Nov 21:S2468-6530(24)00558.
    PubMed         Abstract available


    PLoS One

  54. SALEEM O, Iqbal J
    Blood-glucose regulator design for diabetics based on LQIR-driven Sliding-Mode-Controller with self-adaptive reaching law.
    PLoS One. 2024;19:e0314479.
    PubMed         Abstract available

  55. PAMUNGKASARI EP, Balgis B, Koot J, Landsman J, et al
    Identifying relevant diabetes and hypertension control management guidelines in primary healthcare and community settings in Indonesia: A Delphi survey.
    PLoS One. 2024;19:e0310295.
    PubMed         Abstract available

  56. ZHANG L, Fan D, Zhu T, Geng L, et al
    The ratio of non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol is associated with diabetic kidney disease: A cross-sectional study.
    PLoS One. 2024;19:e0311620.
    PubMed         Abstract available

  57. ADJEI A, Brightson KTC, Mensah MM, Osei J, et al
    Determinants of glycemic control among persons living with type 2 diabetes mellitus attending a district hospital in Ghana.
    PLoS One. 2024;19:e0308046.
    PubMed         Abstract available

  58. KIM M, Heo SJ, Kim MH, Park JW, et al
    Risk factors associated with SGLT2 inhibitor discontinuation in diabetic patients with heart failure.
    PLoS One. 2024;19:e0314305.
    PubMed         Abstract available


    Transplant Proc

  59. LIU C, Chen Q, Sun Z, Liang G, et al
    Pretransplant Diabetes Mellitus and Kidney Transplant Outcomes: A Systematic Review and Meta-Analysis.
    Transplant Proc. 2024 Nov 28:S0041-1345(24)00569.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diabetes is free of charge.